Clinical Trial Update: Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation [EARLY_Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an aldosterone antagonist for prevention of new atrial fibrillation is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Piedmont Healthcare | Conditions: AFib | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING